COR THERAPEUTICS INC
COR Therapeutics is engaged in the discovery, development, and marketing of novel therapeutic products for treating and preventing acute and chronic cardiovascular diseases. The company’s product portfolio includes Integrilin Injection which is used to treat individuals with cardiovascular diseases. COR Therapeutics also has several product development programs underway to address unmet clinical needs in the management of patients suffering from disorders such as unstable angina, coronary angioplasty, acute myocardial infarction, stroke, and deep vein thrombosis. COR Therapeutics was founded by Lee Douglas and Lewis T. ""Rusty"" Williams in San Francisco, California.
COR THERAPEUTICS INC
Industry:
Health Care Medical Therapeutics
Founded:
1988-01-01
Address:
San Francisco, California, United States
Country:
United States
Status:
Active
Similar Organizations
Ceptaris Therapeutics
Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.
My Next Health
My Next Health builds health applications that provide insights into the prevention and treatment of chronic diseases.
Transmural Systems
Transmural Systems is a medical devices company with a platform of percutaneous structural heart therapies for cardiovascular diseases.
Validus Cellular Therapeutics
Validus Cellular Therapeutics is a developer of therapeutic solutions for treating infectious diseases.
Founder
More informations about "COR Therapeutics Inc"
COR Therapeutics 2025 Company Profile: Valuation, Investors
COR Therapeutics has raised $15.9M. Who are COR Therapeutics’s investors? Glynn Capital , InterWest Health Partners , InterWest Partners , Reference Capital Management , and …See details»
COR THERAPEUTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for COR THERAPEUTICS, INC. of South San Francisco, CA. Get the latest business insights from Dun …See details»
COR Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
Jan 23, 2025 The Option was granted pursuant to the Jasper Therapeutics, Inc. Amended and Restated 2022 Inducement Equity Incentive Plan, as approved by the compensation …See details»
Cor Therapeutics - 2025 Company Profile - Tracxn
Cor Therapeutics - Glycoprotein IIb/IIIa inhibitors fro the treatment of cardiovascular diseases.. Acquired by Takeda Oncology. Raised funding from 1 investor. Cor Therapeutics has 312 …See details»
COR Therapeutics Inc - Company Profile and News
COR Therapeutics Inc. discovers and commercializes pharmaceutical products. The Company researches and develops programs that seek to address the critical needs in unstable angina, …See details»
COR Therapeutics Inc - Crunchbase
COR Therapeutics is engaged in the R&D of novel therapeutic products for treating and preventing acute and chronic cardiovascular diseases. Search Crunchbase. Start Free Trial . …See details»
COR Therapeutics - VentureRadar
COR was funded to develop and commercialize innovative pharmaceutical products for the treatment and prevention of severe cardiovascular diseases, such as unstable angina, acute …See details»
COR Therapeutics, Inc. (COR Therapeutics, Inc.) - 药物管线_专利_临 …
Brege has held executive or strategic advisory positions at companies such as BridgeBio Pharma, Inc., Onyx Pharmaceuticals, Inc., and COR Therapeutics, Inc., and has led multiple functions …See details»
Cor Therapeutics Inc - South San Francisco , CA - Company Profile
Cor Therapeutics Inc CLAIM THIS BUSINESS. 256 E GRAND AVE SOUTH SAN FRANCISCO, CA 94080 Get Directions (650) 244-6800. Business Info. Founded 1988; Incorporated DE; …See details»
COR Therapeutics, Inc. - discovery.patsnap.com
COR Therapeutics Inc is headquartered in United States California. COR Therapeutics Inc was founded in 1988. and was founded by David Phillips, Lee Douglas, Lewis Williams. Related …See details»
Millennium and Cor Therapeutics agree to merge creating …
Jan 9, 2002 Millennium Pharmaceuticals Inc and Cor Therapeutics Inc have signed a definitive agreement for Millennium to acquire Cor in a stock-for-stock exchange valued at $2.0 billion. …See details»
Millennium Pharmaceuticals - teaserclub.com
COR Therapeutics was founded by Lee Douglas and Lewis T. ""Rusty"" Williams in San Francisco, California. LeukoSite. Acquisition. in 1999 . LeukoSite develops small molecule and …See details»
Cor Therapeutics - Overview, News & Similar companies - ZoomInfo
Nov 11, 2020 Who is Cor Therapeutics. X-COR Therapeutics is a Boston-based medical device company creating the first commercially available carbon dioxide removal device that uses …See details»
COR Therapeutics - Products, Competitors, Financials, Employees ...
Global Blood Therapeutics Raises $40.7M in Series A Financing - FinSMEs. Feb 26, 2024. Global Blood Therapeutics, Inc. , a San Francisco, CA-based newly formed product-focused company …See details»
Dr. Dennis K. McBride - Top Scientists
Dec 19, 2024 He was a program manager for advanced command, control, and communication technologies at the Defense Advanced Research Projects Agency from 2010 to 2012 and …See details»
COR Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
Explore COR Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 5 news, and 93 literature, Drug:EGR-Xa.See details»
Capricor Therapeutics Announces FDA Acceptance and Priority …
SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for …See details»
CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer …
6 days ago Shares of Corcept Therapeutics Incorporated CORT were up a staggering 109.1% on March 31 after the company announced data from ... NVDA NVIDIA Corporation 109.35 …See details»
Corcept shares soar after Phase 3 win in ovarian cancer
6 days ago Corcept Therapeutics’ oral glucocorticoid receptor antagonist has improved survival outcomes in a late-stage test in patients with a challenging form of ovarian cancer, sending its …See details»
Ovid Therapeutics : April 2025 Corporate Presentation
2 days ago Ovid Therapeutics Inc. is a biopharmaceutical company. The Company is focused on improving the lives of people affected by certain epilepsies and brain conditions with seizure …See details»